YMRC
TMDX icon

Yorktown Management & Research Company’s Transmedics TMDX Stock Holding History

Yorktown Management & Research Company’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,800
Closed -$577K – 285
2026
Q1 		$577K Buy
5,800
+2,300
+66% +$300K 0.48% 63
2025
Q4 		$426K Hold
3,500
– – 0.34% 115
2025
Q3 		$393K Buy
+3,500
New +$410K 0.31% 126

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Yorktown Management & Research Company's TMDX Position: Q2 2026 in Review

Yorktown Management & Research Company sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 5,800 shares — an estimated $577K sold.

Yorktown Management & Research Company first reported a position in TMDX in Q3 2025 and held it in 3 quarters. The position peaked at $577K in Q1 2026. 177 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Yorktown Management & Research Company reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Yorktown Management & Research Company sold 5,800 Transmedics shares in Q2 2026, an estimated $577K.
  • Yorktown Management & Research Company first reported a position in Transmedics in Q3 2025 and held it in 3 quarters.
  • Yorktown Management & Research Company's Transmedics position peaked at $577K in Q1 2026.
  • 177 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.